{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:00:05Z","timestamp":1792011605409,"version":"4.4.0"},"reference-count":21,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2026,9]]},"abstract":"Abstract<\/jats:title>\n \n Purpose<\/jats:title>\n To perform a head\u2010to\u2010head comparison of two extended range of field intraocular lenses (IOLs) for their patient\u2010reported outcome measures.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n Keye Eye Hospital, Seoul, Korea.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Clinical cohort study.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Eighty\u2010five emmetropic bilaterally operated patients (PureSee [\n N<\/jats:italic>\n \u2009=\u200934] vs. AcrySof Vivity [\n N<\/jats:italic>\n \u2009=\u200951]) were compared for their visual outcomes, dysphotopsia (scale 0\u2013100), and spectacle\u2010independent visual function index (VF)\u201014 questionnaire scores at the 6\u2010month timepoint.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Baseline patient and ophthalmic variables were comparable between the groups. Acrysof Vivity provided better uncorrected near (0.21\u2009\u00b1\u20090.10 vs. 0.28\u2009\u00b1\u20090.07 LogMAR units,\n p<\/jats:italic>\n \u2009<\u20090.001) and intermediate visual acuities (0.08\u2009\u00b1\u20090.09 vs. 0.22\u2009\u00b1\u20090.08 LogMAR units,\n p<\/jats:italic>\n \u2009<\u20090.001) compared with PureSee. In contrast, contrast sensitivities in photopic (1.57\u2009\u00b1\u20090.14 vs. 1.45\u2009\u00b1\u20090.17 LogCWeber,\n p<\/jats:italic>\n \u2009=\u20090.024) and mesopic conditions (1.30\u2009\u00b1\u20090.12 vs. 1.19\u2009\u00b1\u20090.17 LogCWeber,\n p<\/jats:italic>\n \u2009=\u20090.025) were greater for PureSee than Acrysof Vivity. PureSee was associated with overall mean dysphotopsia scores (1.3\u2009\u00b1\u20093.2 vs. 5.8\u2009\u00b1\u20099.3,\n p<\/jats:italic>\n \u2009=\u20090.009) significantly less than for Acrysof Vivity. Spectacle\u2010independent VF\u201014 scores for visual acuities at near, specifically reading small print (76.0\u2009\u00b1\u200920.0 vs. 65.9\u2009\u00b1\u200922.4,\n p<\/jats:italic>\n \u2009=\u20090.046), newspaper or a book (94.8\u2009\u00b1\u200911.5 vs. 80.3\u2009\u00b1\u200919.5,\n p<\/jats:italic>\n \u2009<\u20090.001), and large\u2010print or numbers on a telephone (88.0\u2009\u00b1\u200915.4 vs. 79.5\u2009\u00b1\u200918.2,\n p<\/jats:italic>\n \u2009=\u20090.030) were significantly greater for Acrysof Vivity than PureSee, whereas overall mean spectacle\u2010independent VF\u201014 scores remained statistically non\u2010significant for the two IOLs (92.6\u2009\u00b1\u20095.7 vs. 89.3\u2009\u00b1\u20099.7, respectively;\n p<\/jats:italic>\n \u2009=\u20090.115).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Acrysof Vivity was associated with greater spectacle\u2010independent near visual acuity and visual function for reading, while PureSee outperformed in photopic and mesopic contrast sensitivities, glare, starburst, and overall dysphotopsia. Based on these pros and cons, optimal extended range of field IOL selection should be aligned with the individual's needs and concerns.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/aos.70076","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:46:04Z","timestamp":1769834764000},"page":"649-655","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient\u2010reported outcome measures after non\u2010diffractive extended range of field\n IOL<\/scp>\n implantation:\n PureSee<\/scp>\n versus Vivity"],"prefix":"10.1111","volume":"104","author":[{"given":"Kyungmin","family":"Koh","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Kim's Eye Hospital Konyang University College of Medicine Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-8125","authenticated-orcid":false,"given":"Raimo","family":"Tuuminen","sequence":"additional","affiliation":[{"name":"Helsinki Retina Research Group, Faculty of Medicine University of Helsinki Helsinki Finland"},{"name":"Department of Ophthalmology Kymenlaakso Central Hospital Kotka Finland"},{"name":"Faculty of Health Sciences Ben\u2010Gurion University of the Negev Beer\u2010Sheva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Gyu","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kim's Eye Hospital Konyang University College of Medicine Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-0963","authenticated-orcid":false,"given":"Sohee","family":"Jeon","sequence":"additional","affiliation":[{"name":"Keye Eye Center Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03041-0"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20250221-02"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05245-6"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001544"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03040-1"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03039-8"},{"key":"e_1_2_7_8_1","unstructured":"Food and Drug Administration. (2020)Summary of Safety and Effectiveness Data (SSED): AcrySof IQ Vivity Extended Vision IOL (Model DFT015). P930014\/S126. Silver Spring MD: US Department of Health and Human Services. Available from:https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P930014S126B.pdf[Accessed 20th November 2025]."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69960-w"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20241230-01"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14144967"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000000826"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000000109"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07970-y"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001123"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001502"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001113"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090170074026"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.03.017"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.17560"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2025.10.001"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.jcrs.0000000000001615"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.70076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.70076","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.70076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:24:41Z","timestamp":1786465481000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.70076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/aos.70076"],"URL":"https:\/\/doi.org\/10.1111\/aos.70076","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}